Retrospective review of dosing trends in botulinum toxin injections for the treatment of adductor spasmodic dysphonia in a long-term cohort
Abstract Background Botulinum toxin A (BT) is the gold standard treatment for adductor spasmodic dysphonia (AdSD) with established use for greater than thirty years. The spasmodic dysphonia (SD) literature would benefit from additional long-term cohort data, especially in the Canadian population. Th...
Saved in:
Main Authors: | Gabrielle French, J. Douglas Bosch, Derrick R. Randall |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-01-01
|
Series: | Journal of Otolaryngology - Head and Neck Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40463-020-0401-4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Case report: Dysphonia associated with high-dose cytarabine therapy
by: Ling Ma, et al.
Published: (2025-01-01) -
Patient-centred evaluation of a reduced dose of botulinum toxin A in the management of myofascial pain
by: Alice Cameron, et al.
Published: (2025-03-01) -
The Effect of Different Doses of Botulinum Toxin on Masseter Muscle in Patients with Bruxism.
by: Kawa F. Dizaye, et al.
Published: (2022-02-01) -
Intragastric botulinum toxin injection: a promising alternative for obesity treatment?
by: Hakan Balbaloglu, et al.
Published: (2024-10-01) -
Intragastric botulinum toxin injection for weight loss: current trends, shortcomings and future perspective
by: Erfan Arabpour, et al.
Published: (2025-01-01)